190 related articles for article (PubMed ID: 23141945)
21. Translocation (8;22) in cold agglutinin disease associated with B-cell lymphoma.
Chng WJ; Chen J; Lim S; Chong SM; Kueh YK; Lee SH
Cancer Genet Cytogenet; 2004 Jul; 152(1):66-9. PubMed ID: 15193444
[TBL] [Abstract][Full Text] [Related]
22. Deletion of C-MYC in the spectrum of transformed follicular lymphoma grade 3b.
Tzankov A; Höllrigl A; Verdorfer I; Oxle H
Hum Pathol; 2007 Jan; 38(1):191-2; author reply 192-3. PubMed ID: 17169631
[No Abstract] [Full Text] [Related]
23. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
24. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
25. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.
Wang HY; Bossler AD; Schaffer A; Tomczak E; DiPatri D; Frank DM; Nowell PC; Bagg A
Cancer Genet Cytogenet; 2007 Jan; 172(1):45-53. PubMed ID: 17175379
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ
Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178
[TBL] [Abstract][Full Text] [Related]
27. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
28. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
29. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.
Frost M; Newell J; Lones MA; Tripp SR; Cairo MS; Perkins SL
Am J Clin Pathol; 2004 Mar; 121(3):384-92. PubMed ID: 15023043
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations.
Niitsu N; Okamoto M; Miura I; Hirano M
Leukemia; 2009 Apr; 23(4):777-83. PubMed ID: 19151788
[TBL] [Abstract][Full Text] [Related]
31. Pathology, pathogenesis and molecular genetics of follicular NHL.
Leich E; Ott G; Rosenwald A
Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
[TBL] [Abstract][Full Text] [Related]
32. t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma.
Niitsu N; Okamoto M; Yoshino T; Nakamine H; Nakamura N; Bessho M; Hirano M; Miura I
Leuk Res; 2007 May; 31(5):707-11. PubMed ID: 16887184
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
[TBL] [Abstract][Full Text] [Related]
34. Plasmablastic lymphoma affecting the lung and bone marrow with CD10 expression and t(8;14)(q24;q32) translocation.
Chuah KL; Ng SB; Poon L; Yap WM
Int J Surg Pathol; 2009 Apr; 17(2):163-6. PubMed ID: 18508845
[TBL] [Abstract][Full Text] [Related]
35. [Pitfalls and update in haematopathology. Case 7. Nodular lymphocyte predominant Hodgkin lymphoma].
Moreau A
Ann Pathol; 2012 Oct; 32(5):363-70. PubMed ID: 23141946
[No Abstract] [Full Text] [Related]
36. [Pitfalls and update in haematopathology. Case 2. "Early phase" mantle cell lymphoma of the lymph node].
Copie-Bergman C
Ann Pathol; 2012 Oct; 32(5):336-40. PubMed ID: 23141941
[No Abstract] [Full Text] [Related]
37. MYC and aggressive B-cell lymphomas.
Slack GW; Gascoyne RD
Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
[TBL] [Abstract][Full Text] [Related]
38. High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients.
Shia AK; Gan GG; Jairaman S; Peh SC
J Clin Pathol; 2005 Sep; 58(9):962-7. PubMed ID: 16126878
[TBL] [Abstract][Full Text] [Related]
39. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
40. Specific patterns of chromosomal gains and losses associate with t(3;14), t(8;14), and t(14;18) in diffuse large B-cell lymphoma.
Sheth A; de Melo VA; Szydlo R; Macdonald DH; Reid AG; Wagner SD
Cancer Genet Cytogenet; 2009 Oct; 194(1):48-52. PubMed ID: 19737654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
